Navigation Links
Ranpirnase Receives Orphan Drug Designation from US FDA for Treatment of Ebola Virus Disease
Date:8/8/2017

Tamir Biotechnology, a leading developer of antiviral therapies, announced that ranpirnase has received Orphan Drug Designation (ODD) from the US FDA for the treatment of Ebola Virus Disease. The designation was based on laboratory and animal data demonstrating the safety and efficacy as both treatment and prevention of Ebola virus infection. “This designation by the FDA reinforces what we already know—ranpirnase is an effective broad-spectrum antiviral,” said Dr. Tom Hodge, Executive Director of Pre-Clinical and Antiviral Research, Tamir Biotechnology. Added Dr. Hodge, “Combined with our advanced clinical development as a first-line agent for the treatment of human papilloma virus (HPV) skin infections, Tamir’s pipeline is robust and focused on areas of unmet medical need.”

Given ranpirnase has an extensive clinical and manufacturing history as a previously studied oncolytic, the company expects an accelerated timeline further progressing the development of ranpirnase in the HPV and the oral and genital Herpes Simplex virus (HSV-1 and HSV-2) space. The antiviral effect against HPV, HSV and the already known anti-HIV activity will make ranpirnase an important tool in treatment and prevention of sexually transmitted diseases and devastating worldwide viral diseases.

For further information, please contact thodge(at)tamirbio.com.

Read the full story at http://www.prweb.com/releases/2017/08/prweb14578522.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. Living Well Assisted Living at Home Receives Artwork for Display
2. Woman with Type I Diabetes Receives Life-Changing Grant from Core Fitness Solution
3. Penn Medicine receives award from Patient-Centered Outcomes Research Institute
4. Countervail Corporation Receives Additional $5.4 Million from BARDA For Continued Development of Medical Countermeasure to Nerve Agents
5. Nemours receives Dept. of Defense award to study physicians maintenance of optimal clinical program
6. LSUHSCs Rodriguez receives cancer immunotherapy Presidential Award
7. Halo Therapeutics Receives $500,000 MDA Award to Develop Drug for Duchenne Muscular Dystrophy
8. Mount Sinais Arvin Dar, Ph.D., receives NIH New Innovator Award for drug development
9. FusionHealth Receives HealthCare Consumerism Superstar Industry Innovator Award
10. Home Care Assistance of Cincinnati Receives Home Care Pulse Certification
11. University of Tennessee professor receives Gates Foundation Award to reinvent condom, improve global health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... CT (PRWEB) , ... October 13, 2017 , ... ... long-term care services, staged a mock evacuation of the facility as part of a ... Shelton Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well as ...
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released ... understood books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture ... Many have tossed it off as mere rubbish, but Yisrayl Hawkins says that is ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... for healthcare compliance program management, will showcase a range of technology and learning ... Assisted Living (NCAL) Convention and Expo to be held October 14–18, 2017 at ...
(Date:10/12/2017)... ... 2017 , ... The American College of Medical Informatics (ACMI) will present the ... Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium ... a pioneer in the field of medical informatics, this prestigious award is presented to ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... for the 49th Congress of the International Society of Paediatric Oncology (SIOP) ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... MENLO PARK, Calif. , Oct. 11, 2017 /PRNewswire/ ... a national scientific team that developed an innovative way ... and quantity of the delivery of new drugs. ... the 2017 Fall Clinical Dermatology Conference will show how ... Massachusetts General Hospital, Harvard Medical School used a suite ...
(Date:10/11/2017)... , Oct. 11, 2017  True Health, ... has amplified its effort during National Breast Cancer ... hereditary cancer risks. ... Clinical Oncology calculated that more than 10 million ... inherited mutations in BRCA1 or BRCA2 and have not ...
(Date:10/10/2017)... -- NDS received FDA 510(k) clearance in May 2017 for its highly ... designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... support the improvement of patient outcomes, procedural efficiency, and the lowering ... ... ...
Breaking Medicine Technology: